Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
03 2022
Historique:
received: 05 07 2021
accepted: 20 12 2021
entrez: 7 3 2022
pubmed: 8 3 2022
medline: 15 4 2022
Statut: ppublish

Résumé

Adolescents living with HIV are subject to multiple co-morbidities, including growth retardation and immunodeficiency. We describe growth and CD4 evolution during adolescence using data from the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) global project. Data were collected between 1994 and 2015 from 11 CIPHER networks worldwide. Adolescents with perinatally acquired HIV infection (APH) who initiated antiretroviral therapy (ART) before age 10 years, with at least one height or CD4 count measurement while aged 10-17 years, were included. Growth was measured using height-for-age Z-scores (HAZ, stunting if <-2 SD, WHO growth charts). Linear mixed-effects models were used to study the evolution of each outcome between ages 10 and 17. For growth, sex-specific models with fractional polynomials were used to model non-linear relationships for age at ART initiation, HAZ at age 10 and time, defined as current age from 10 to 17 years of age. A total of 20,939 and 19,557 APH were included for the growth and CD4 analyses, respectively. Half were females, two-thirds lived in East and Southern Africa, and median age at ART initiation ranged from <3 years in North America and Europe to >7 years in sub-Saharan African regions. At age 10, stunting ranged from 6% in North America and Europe to 39% in the Asia-Pacific; 19% overall had CD4 counts <500 cells/mm Growth patterns during adolescence differed substantially by sex and region, while CD4 patterns were similar, with an observed CD4 decline that needs further investigation. Early diagnosis and timely initiation of treatment in early childhood to prevent growth retardation and immunodeficiency are critical to improving APH growth and CD4 outcomes by the time they reach adulthood.

Identifiants

pubmed: 35255197
doi: 10.1002/jia2.25871
pmc: PMC8901148
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25871

Subventions

Organisme : NICHD NIH HHS
ID : U01 HD052104
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI096299
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW011295
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069421
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00004/03
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : U01 AI069911
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068616
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069919
Pays : United States
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069923
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI124872
Pays : United States

Informations de copyright

© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

PLoS One. 2015 Dec 14;10(12):e0144057
pubmed: 26658814
AIDS Care. 2015;27(7):805-16
pubmed: 25702789
Lancet Child Adolesc Health. 2020 Sep;4(9):688-698
pubmed: 32359507
PLoS One. 2019 Nov 14;14(11):e0224837
pubmed: 31725750
AIDS Res Hum Retroviruses. 2020 Oct;36(10):821-830
pubmed: 32524856
Am J Clin Nutr. 2013 May;97(5):911-8
pubmed: 23553163
AIDS. 2017 Jun 1;31(9):1333-1341
pubmed: 28358737
J Int AIDS Soc. 2019 Sep;22(9):e25379
pubmed: 31498566
J Int AIDS Soc. 2018 Dec;21(12):e25215
pubmed: 30548817
PLoS One. 2019 Oct 17;14(10):e0223655
pubmed: 31622391
J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):88-96
pubmed: 32188991
HIV Med. 2018 Oct;19(9):668-672
pubmed: 30084150
PLoS Med. 2013 Oct;10(10):e1001542
pubmed: 24204216
Trop Med Int Health. 2019 Jun;24(6):775-785
pubmed: 30945378
HIV Med. 2018 Mar;19(3):184-194
pubmed: 29230953
South Afr J HIV Med. 2020 Feb 03;21(1):1031
pubmed: 32158557
BMC Pediatr. 2019 Aug 17;19(1):287
pubmed: 31421667
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
J Int AIDS Soc. 2020 May;23(5):e25488
pubmed: 32438498
PLoS Pathog. 2014 May 15;10(5):e1004078
pubmed: 24831517
PLoS Med. 2018 Mar 1;15(3):e1002514
pubmed: 29494593
AIDS Res Hum Retroviruses. 2020 Jul;36(7):566-573
pubmed: 32138527
Curr Opin HIV AIDS. 2018 May;13(3):179-186
pubmed: 29432228
AIDS. 2014 Aug 24;28(13):1945-56
pubmed: 24845154
Curr Opin HIV AIDS. 2018 May;13(3):220-229
pubmed: 29461328
Clin Infect Dis. 2016 May 15;62(10):1297-1303
pubmed: 26908792
J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):131-140
pubmed: 32463083
J Infect Dis. 2012 Feb 15;205(4):548-56
pubmed: 22205102
AIDS. 2019 Oct 1;33(12):1897-1910
pubmed: 31274534
Clin Infect Dis. 2007 Sep 15;45(6):785-94
pubmed: 17712765
J Consult Clin Psychol. 2014 Oct;82(5):920-30
pubmed: 24491071
J Pediatr Endocrinol Metab. 2013;26(7-8):639-44
pubmed: 23612635
Clin Infect Dis. 2020 Jan 16;70(3):404-415
pubmed: 30919882
AIDS. 2020 Feb 1;34(2):261-266
pubmed: 31651427
Front Nutr. 2014 Aug 15;1:13
pubmed: 25988116
AIDS. 2015 Oct 23;29(16):2109-19
pubmed: 26182197
PLoS One. 2019 Aug 5;14(8):e0220552
pubmed: 31381604
J Int AIDS Soc. 2018 Feb;21 Suppl 1:
pubmed: 29485724
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
AIDS. 2018 Sep 10;32(14):1977-1982
pubmed: 29927784
AIDS. 2015 Mar 13;29(5):609-18
pubmed: 25710288
J Immunol Res. 2020 May 16;2020:8041616
pubmed: 32509884
Curr Opin HIV AIDS. 2018 May;13(3):236-248
pubmed: 29528851
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):510-518
pubmed: 30142143
Eur J Haematol. 2008 Jun;80(6):532-9
pubmed: 18284628
Immunol Rev. 2013 Jul;254(1):78-101
pubmed: 23772616
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1:S58-S62
pubmed: 29994921
Stat Methods Med Res. 2018 Jul;27(7):2015-2023
pubmed: 29846144
AIDS. 2014 Jul 17;28(11):1645-55
pubmed: 24804858
AIDS. 2018 May 15;32(8):1043-1051
pubmed: 29547445
PLoS One. 2019 May 31;14(5):e0217742
pubmed: 31150489
Pediatr Infect Dis J. 2015 Jul;34(7):e159-68
pubmed: 25955835
AIDS. 2016 Jan;30(2):327-30
pubmed: 26186129
PLoS One. 2017 Dec 29;12(12):e0190332
pubmed: 29287090
AIDS. 2015 Sep 24;29(15):2009-23
pubmed: 26355573
J Int AIDS Soc. 2019 Nov;22(11):e25412
pubmed: 31702088
Trop Med Int Health. 2016 May;21(5):619-29
pubmed: 26914715

Auteurs

Julie Jesson (J)

CERPOP, Inserm, Université Paul Sabatier Toulouse 3, Toulouse, France.

Siobhan Crichton (S)

MRC Clinical Trials Unit, University College London, London, UK.

Matteo Quartagno (M)

MRC Clinical Trials Unit, University College London, London, UK.

Marcel Yotebieng (M)

Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Elaine J Abrams (EJ)

ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, USA.

Kulkanya Chokephaibulkit (K)

Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Salaya, Thailand.

Sophie Le Coeur (S)

Institut National d'Etude Demographique (INED), Mortality, Health and Epidemiology Unit, Paris, France.
Institut de Recherche pour le Developpement (IRD), UMI-174/PHPT, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.

Marie-Hélène Aké-Assi (MH)

University Hospital Yopougon, Abidjan, Côte d'Ivoire.

Kunjal Patel (K)

Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

Jorge Pinto (J)

Department of Pediatrics, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Mary Paul (M)

Baylor International Pediatric AIDS Initiative, Texas Children's Hospital-USA, Houston, Texas, USA.

Rachel Vreeman (R)

Department of Global Health, Icahn School of Medicine at Mount Sinai, New York, USA.

Mary-Ann Davies (MA)

School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Jihane Ben-Farhat (J)

Epicentre, Médecins Sans Frontières, Paris, France.

Russell Van Dyke (R)

Tulane University Health Sciences Center, New Orleans, Louisiana, USA.

Ali Judd (A)

MRC Clinical Trials Unit, University College London, London, UK.

Lynne Mofenson (L)

Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.

Marissa Vicari (M)

International AIDS Society, Geneva, Switzerland.

George Seage (G)

University Hospital Yopougon, Abidjan, Côte d'Ivoire.

Linda-Gail Bekker (LG)

Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.

Shaffiq Essajee (S)

UNICEF, New York, USA.

Diana Gibb (D)

MRC Clinical Trials Unit, University College London, London, UK.

Martina Penazzato (M)

HIV Department, World Health Organization, Geneva, Switzerland.

Intira Jeannie Collins (IJ)

MRC Clinical Trials Unit, University College London, London, UK.

Kara Wools-Kaloustian (K)

Indiana University School of Medicine, Indianapolis, Indiana, USA.

Amy Slogrove (A)

Department of Paediatrics & Child Health, Faculty of Medicine & Health Sciences, Stellenbosch University, Worcester, South Africa.

Kate Powis (K)

University Hospital Yopougon, Abidjan, Côte d'Ivoire.

Paige Williams (P)

University Hospital Yopougon, Abidjan, Côte d'Ivoire.

Mogomotsi Matshaba (M)

Baylor College of Medicine Children's Foundation, Lilongwe, Botswana.

Lineo Thahane (L)

Baylor College of Medicine Children's Foundation, Maseru, Lesotho.

Phoebe Nyasulu (P)

Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.

Bhekumusa Lukhele (B)

Baylor College of Medicine Children's Foundation, Mbabane, eSwatini.

Lumumba Mwita (L)

Baylor College of Medicine Children's Foundation, Mwanza, Tanzania.

Adeodata Kekitiinwa-Rukyalekere (A)

Baylor College of Medicine Children's Foundation, Kampala, Uganda.

Sebastian Wanless (S)

Department of Pediatrics, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Tessa Goetghebuer (T)

Hospital St Pierre, Brussels, Belgium.

Claire Thorne (C)

UCL Great Ormond Street Institute of Child Health, University College London, London, UK.

Josiane Warszawski (J)

Inserm U1018, Centre de recherche en Epidémiologie et Santé des Populations, Paris, France.

Luisa Galli (L)

Infection Disease Unit, Meyer Children's University Hospital, Florence, Italy.
Department of Health Sciences, University of Florence, Florence, Italy.

Annemarie M C van Rossum (AMC)

Erasmus MC University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.

Carlo Giaquinto (C)

Padova University/PENTA Foundation, Padua, Italy.

Magdalena Marczynska (M)

Medical University of Warsaw, Hospital of Infectious Diseases in Warsaw, Warsaw, Poland.

Laura Marques (L)

Centro Hospitalar do Porto, Porto, Portugal.

Filipa Prata (F)

Hospital de Santa Maria, Lisboa, Portugal.

Luminita Ene (L)

Victor Babes Hospital, Bucharest, Romania.

Lyuba Okhonskaya (L)

Republican Hospital of Infectious Diseases, St Petersburg, Russian Federation.

Marisa Navarro (M)

Hospital General Universitario "Gregorio Marañón", Madrid, Spain.

Antoinette Frick (A)

Hospital Universitari Vall d' Hebron, Vall d' Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.

Lars Naver (L)

Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

Christian Kahlert (C)

Children's Hospital of Eastern Switzerland, Saint Gallen, Switzerland.

Alla Volokha (A)

Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine.

Elizabeth Chappell (E)

MRC Clinical Trials Unit, University College London, London, UK.

Jean William Pape (JW)

GHESKIO Center, Port-au-Prince, Haiti.

Vanessa Rouzier (V)

GHESKIO Center, Port-au-Prince, Haiti.

Adias Marcelin (A)

GHESKIO Center, Port-au-Prince, Haiti.

Regina Succi (R)

Universidade Federal de Sao Paulo, Sao Paulo, Brazil.

Annette H Sohn (AH)

TREAT Asia/amfAR, Bangkok, Thailand.

Azar Kariminia (A)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Andrew Edmonds (A)

Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Patricia Lelo (P)

Pediatric Hospital Kalembe Lembe, Lingwala, Demogratic Republic of Congo.

Rita Lyamuya (R)

Morogoro Regional Hospital, Morogoro, Tanzania.

Edith Apondi Ogalo (EA)

Moi Teaching and Referral Hospital, Eldoret, Kenya.

Francesca Akoth Odhiambo (FA)

Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Andreas D Haas (AD)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Carolyn Bolton (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Josephine Muhairwe (J)

SolidarMed, Lesotho, Zimbabwe.

Hannock Tweya (H)

Lighthouse Trust Clinic, Lilongwe, Malawi.

Mariam Sylla (M)

CHU Gabriel Toure, Bamako, Mali.

Marceline D'Almeida (M)

Centre National Hospitalier Universitaire Hubert K. Maga, Cotonou, Benin.

Lorna Renner (L)

Korle Bu Teaching Hospital, Accra, Ghana.

Mark J Abzug (MJ)

University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.

James Oleske (J)

Rutgers - New Jersey Medical School, Newark, New Jersey, USA.

Murli Purswani (M)

Bronx-Lebanon Hospital Center, Bronx, New York, USA.

Chloe Teasdale (C)

ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, USA.

Harriet Nuwagaba-Biribonwoha (H)

ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, USA.

Ruth Goodall (R)

MRC Clinical Trials Unit, University College London, London, UK.

Valériane Leroy (V)

CERPOP, Inserm, Université Paul Sabatier Toulouse 3, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH